We are live on
!
Find out more
EMG
ETF Managers Group Portfolio holdings
AUM
$3.1B
1-Year Est. Return
17.12%
This Fund
S&P 500
This Quarter
Est. Return
+18.48%
1 Year Est. Return
-17.12%
3 Year Est. Return
+77.69%
5 Year Est. Return
+63.88%
10 Year Est. Return
–
AUM
$5.63B
AUM Growth
+$1.07B
(+23%)
Cap. Flow
+$732M
Cap. Flow
% of AUM
13%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
695
New
78
Increased
409
Reduced
177
Closed
27
Top Buys
| 1 |
Cognyte Software
CGNT
|
+$51.8M |
| 2 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$45.4M |
| 3 |
Mativ Holdings
MATV
|
+$37.9M |
| 4 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$37.4M |
| 5 |
Altria Group
MO
|
+$34.6M |
Top Sells
| 1 |
Tilray
TLRY
|
+$43M |
| 2 |
APHA
Aphria Inc. Common Shares
APHA
|
+$40M |
| 3 |
VRNT
Verint Systems
VRNT
|
+$35.2M |
| 4 |
GameStop
GME
|
+$18.6M |
| 5 |
ABST
Absolute Software Corp
ABST
|
+$18M |
Sector Composition
| 1 | Technology | 42.27% |
| 2 | Healthcare | 15.02% |
| 3 | Materials | 12.66% |
| 4 | Financials | 7.72% |
| 5 | Consumer Staples | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HOLX
551
DELISTED
Hologic
HOLX
| $380K | 0.01% |
5,145
-28
| -0.5% | -$2.13K |
|
552
Regeneron Pharmaceuticals
REGN
$71.8B
| $379K | 0.01% |
806
+54
| +7% | +$26.3K |
|
553
Cannae Holdings
CNNE
$666M
| $378K | 0.01% |
9,589
+1,288
| +16% | +$52.1K |
|
|
PPLI
554
People Inc
PPLI
$3.32B
| $378K | 0.01% |
3,360
+524
| +18% | +$65.1K |
|
555
FTI Consulting
FCN
$4.96B
| $375K | 0.01% |
2,676
+357
| +15% | +$42.3K |
|
556
Gilead Sciences
GILD
$172B
| $375K | 0.01% |
5,727
-434
| -7% | -$28K |
|
557
Abbott
ABT
$176B
| $374K | 0.01% |
3,121
-366
| -10% | -$43.4K |
|
558
iHeartMedia
IHRT
$586M
| $374K | 0.01% |
+20,702
| New | +$313K |
|
|
ALXN
559
DELISTED
Alexion Pharmaceuticals
ALXN
| $374K | 0.01% |
2,437
-660
| -21% | -$102K |
|
560
Andersons Inc
ANDE
$2.66B
| $373K | 0.01% |
13,440
-6,307
| -32% | -$167K |
|
|
ESPR
561
DELISTED
Esperion Therapeutics
ESPR
| $373K | 0.01% |
+13,579
| New | +$401K |
|
562
Armstrong World Industries
AWI
$6.83B
| $371K | 0.01% |
4,042
+539
| +15% | +$45.8K |
|
|
TBIO
563
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $370K | 0.01% |
23,039
-13,111
| -36% | -$299K |
|
564
Blackrock
BLK
$167B
| $367K | 0.01% |
490
-490
| -50% | -$355K |
|
|
CERN
565
DELISTED
Cerner Corp
CERN
| $366K | 0.01% |
5,107
+686
| +16% | +$51.5K |
|
|
CMCM
566
Cheetah Mobile
CMCM
$97.2M
| $365K | 0.01% |
32,017
-39,154
| -55% | -$501K |
|
567
Microvision
MVIS
$108M
| $359K | 0.01% |
+29,136
| New | +$366K |
|
568
California Water Service
CWT
$3.08B
| $357K | 0.01% |
6,404
+861
| +16% | +$47.7K |
|
569
Enphase Energy
ENPH
$5.42B
| $356K | 0.01% |
2,361
-18,136
| -88% | -$3.26M |
|
570
Centene
CNC
$31.8B
| $354K | 0.01% |
5,409
+728
| +16% | +$45.1K |
|
571
Blackbaud
BLKB
$1.5B
| $353K | 0.01% |
5,035
-176
| -3% | -$12.1K |
|
572
Chegg
CHGG
$87.7M
| $352K | 0.01% |
4,221
-1,334
| -24% | -$127K |
|
573
8x8 Inc
EGHT
$288M
| $352K | 0.01% |
11,189
+12
| +0.1% | +$415 |
|
574
Nektar Therapeutics
NKTR
$2.31B
| $351K | 0.01% |
1,200
+161
| +15% | +$50.1K |
|
575
Avient
AVNT
$3.44B
| $350K | 0.01% |
+7,335
| New | +$327K |
|
Similar funds
AIA
PFM
DKP
HT
JCG
QA
BFG
IMOV
ETF Managers Group's Q1 2021 Portfolio in Review
As of Q1 2021, ETF Managers Group held 695 positions worth $5.63B, up 23% from $4.56B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
ETF Managers Group deployed $732M of net new capital in Q1 2021, opening 78 new positions and adding to 409 existing holdings. Its largest new stake was Cognyte Software: 1,743,286 shares worth $47.8M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 52% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Tilray, an estimated $43M trimmed.
- ETF Managers Group's largest Q1 2021 buy was Cognyte Software: 1,743,286 shares worth $47.8M.
- ETF Managers Group added most to GW Pharmaceuticals Plc American Depositary Shares in Q1 2021, an estimated $45.4M increase.
- ETF Managers Group's biggest Q1 2021 reduction was Tilray, cutting an estimated $43M.
- ETF Managers Group fully exited Tvardi Therapeutics in Q1 2021, selling an estimated $6.57M.
- ETF Managers Group's ten largest holdings make up 20% of its $5.63B portfolio in Q1 2021.
- ETF Managers Group opened 78 new positions and closed 27 in Q1 2021.
- ETF Managers Group's portfolio value rose 23% quarter-over-quarter to $5.63B.
Based on ETF Managers Group's 13F filing for Q1 2021, filed 17 May 2021.